Small Molecule Pin1 Inhibitor Blocking NF-κB Signaling in Prostate Cancer Cells.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Chemistry - An Asian Journal

• Publication date

  2018-02-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/asia.201701216PMID 29288531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposing.

  2018cited by this paper
• A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells

  2017cited by this paper
• The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target

  2016cited by this paper
• Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma

  2015cited by this paper
• In silico identification of natural product inhibitors of JAK2.

  2015cited by this paper
• Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

  2015cited by this paper
• Modulating the Affinities of Phosphopeptides for the Human Pin1 WW Domain Using 4-Substituted Proline Derivatives.

  2015cited by this paper
• Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping.

  2014cited by this paper
• Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library.

  2014cited by this paper
• Cancer chemoprevention with green tea catechins: from bench to bed.

  2012cited by this paper
• Structural and kinetic analysis of prolyl-isomerization/phosphorylation cross-talk in the CTD code.

  2012cited by this paper
• Structure‐Based Repurposing of FDA‐Approved Drugs as TNF‐α Inhibitors

  2011cited by this paper
• A reduced-amide inhibitor of Pin1 binds in a conformation resembling a twisted-amide transition state.

  2011cited by this paper
• Prolyl cis/trans isomerase signalling pathways in cancer.

  2011cited by this paper
• Structure-based design of novel human Pin1 inhibitors (II).

  2010cited by this paper
• Pin1 Promotes Transforming Growth Factor-β-induced Migration and Invasion*

  2009cited by this paper
• Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.

  2009cited by this paper
• The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease

  2007cited by this paper
• The Peptidylprolyl cis/trans-Isomerase Pin1 Modulates Stress-induced Dephosphorylation of Tau in Neurons

  2006cited by this paper
• An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets

  2005cited by this paper
• Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation.

  2003cited by this paper
• Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.

  2003cited by this paper
• Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells

  2002cited by this paper
• Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1

  2001cited by this paper
• The Rel/NF-kappa B family: friend and foe.

  2000cited by this paper
• The Rel/NF-κB family: friend and foe

  2000cited by this paper
• Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone.

  1998cited by this paper
• Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. I. Producing strain, fermentation, isolation and biological activity.

  1993cited by this paper

• PknB and STP as potential targets of luteolin in combating Trueperella pyogenes infections

  2025cites this paper
• PKN3 as a key regulator in cancer - From signaling pathways to targeted therapies.

  2025cites this paper
• A structure-based approach to discover a potential isomerase Pin1 inhibitor for cancer therapy using computational simulation and biological studies

  2024cites this paper
• The mechanisms of Pin1 as targets for cancer therapy

  2024cites this paper
• Versatile function of NF-ĸB in inflammation and cancer

  2024cites this paper
• S100A4/NF-κB axis mediates the anticancer effect of epigallocatechin-3-gallate in platinum-resistant ovarian cancer

  2024cites this paper
• The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy.

  2023cites this paper
• The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities

  2023cites this paper
• Strategies targeting endoplasmic reticulum stress to improve Parkinson’s disease

  2023cites this paper
• Targeting a transcription factor NF-κB by green tea catechins using in silico and in vitro studies in pancreatic cancer

  2023influential citation
• Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy.

  2023cites this paper
• Biological Function of Pin1 in Vivo and Its Inhibitors for Preclinical Study: Early Development, Current Strategies, and Future Directions.

  2023cites this paper
• Bresmycins A and B, potent anti-breast cancer indolocarbazole alkaloids from the sponge-associated Streptomyces sp. NBU3142

  2023cites this paper
• A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance

  2022cites this paper
• Targeting PGAM1 in cancer: An emerging therapeutic opportunity.

  2022cites this paper
• Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).

  2021cites this paper
• BCAT1 Promotes Lung Adenocarcinoma Progression Through Enhanced Mitochondrial Respiration and NF-κB Pathway Activation

  2021cites this paper
• A simultaneously GSH-depleted bimetallic Cu(ii) complex for enhanced chemodynamic cancer therapy.

  2020cites this paper
• Ethanol extract of Ophiorrhiza pumila suppresses liver cancer cell proliferation and migration

  2020cites this paper
• Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics

  2020cites this paper
• The inhibition of H1N1 influenza induced apoptosis by sodium selenite through ROS-mediated signaling pathways

  2020cites this paper
• Halo and Pseudohalo Gold(I)-NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent in Vitro and in Vivo Anticancer Activity Against HCC.

  2020cites this paper
• A 7-methoxybicoumarin derivative selectively inhibits BRD4 BD2 for anti-melanoma therapy.

  2020cites this paper
• Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.

  2020cites this paper
• The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.

  2019cites this paper
• The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes.

  2019cites this paper
• Harnessing the Power of Optical Microscopic and Macroscopic Imaging for Natural Products as Cancer Therapeutics

  2019cites this paper
• Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review

  2019cites this paper
• Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes

  2019cites this paper
• Cobalt(II) Diphenylazodioxide Complexes Induce Apoptosis in SK-HEP-1 Cells

  2019cites this paper
• Cancer-Fighting Phytochemicals: Another Look

  2019cites this paper
• Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.

  2019cites this paper
• Insight into the structural stability of wild-type and histidine mutants in Pin1 by experimental and computational methods

  2019cites this paper
• Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy

  2019cites this paper
• Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.

  2019cites this paper
• Structural Basis for the Inhibition of the Autophosphorylation Activity of HK853 by Luteolin

  2019cites this paper
• Oncogenic Hijacking of the PIN1 Signaling Network

  2019cites this paper
• Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway

  2019cites this paper
• The azatryptophan-based fluorescent platform for in vitro rapid screening of inhibitors disrupting IKKβ-NEMO interaction.

  2018cites this paper
• Gears-In-Motion: The Interplay of WW and PPIase Domains in Pin1

  2018cites this paper
• Prolyl isomerase Pin1: a promoter of cancer and a target for therapy

  2018cites this paper